Literature DB >> 10936415

PPARgamma: observations in the hematopoietic system.

M E Greene1, J Pitts, M A McCarville, X S Wang, J A Newport, C Edelstein, F Lee, S Ghosh, S Chu.   

Abstract

Human Peroxisome Proliferator-Activated Receptor gamma (PPARgamma) was originally cloned from a human bone marrow library. What role does this ligand activated transcription factor play in hematopoiesis and the immune system? We note that: a) PPARgamma has potential to interact/interfere or synergize with retinoid biology, b) fatty acids and a prostaglandin have been identified as ligands, and c) lymphocytes, monocytes and neutrophils use fatty acids as a major source of energy production, d) PPARgamma has been shown to oppose TNFalpha and down regulate cytokine production in monocytes. Therefore, we undertook a review of the literature and an expression survey of PPARgamma in a number of major organs and cells involved in the hematopoietic system, for the purpose of building a database towards understanding the role and function of PPARgamma gene regulation in the developing blood and immune systems. PPARgamma is expressed before mesodermal induction in tissue in and around Speymann's organizer in the xenopus blastocyst, in erythroid precursors of blood islands and in the circulation of the day 10.0 murine embryo, in human 19 week fetal liver, in some but not all murine and human bone marrow erythroid, myeloid, and monocytoid progenitors, bone marrow stromal cells and adipocytes, osteoblasts, endothelial cells, some T, and B lymphocytes, monocytes, macrophages, and other monocytic derivatives. It can be found in the cells of Peyer's patches, lymphoid follicles, spleen, and thymus. It is not clear if it is ever or transiently expressed in megakaryocytes, mast cells, or neutrophils. Based on the above data and a review of the literature, PPARgamma seems to play a role during the elicitation of immune responses. We propose PPARgamma may be involved in changes in energy states required during activation and development of many cell types involved, and has additional immunologically relevant effects in erythroid, myeloid, monocytic, T and B lymphocytic, stromal, and endothelial cell function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10936415     DOI: 10.1016/s0090-6980(00)00075-7

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  12 in total

1.  Clinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPARγ deficiency.

Authors:  Philippe M Campeau; Olga Astapova; Rebecca Martins; Jean Bergeron; Patrick Couture; Robert A Hegele; Todd Leff; Claude Gagné
Journal:  J Lipid Res       Date:  2012-07-02       Impact factor: 5.922

2.  Therapeutic Implications of PPARgamma in Human Osteosarcoma.

Authors:  Eric R Wagner; Bai-Cheng He; Liang Chen; Guo-Wei Zuo; Wenli Zhang; Qiong Shi; Qing Luo; Xiaoji Luo; Bo Liu; Jinyong Luo; Farbod Rastegar; Connie J He; Yawen Hu; Barrett Boody; Hue H Luu; Tong-Chuan He; Zhong-Liang Deng; Rex C Haydon
Journal:  PPAR Res       Date:  2010-02-16       Impact factor: 4.964

Review 3.  Impact of conjugated linoleic acid on bone physiology: proposed mechanism involving inhibition of adipogenesis.

Authors:  Steven W Ing; Martha A Belury
Journal:  Nutr Rev       Date:  2011-02-14       Impact factor: 7.110

Review 4.  Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity.

Authors:  Amanda Janesick; Bruce Blumberg
Journal:  Birth Defects Res C Embryo Today       Date:  2011-03

Review 5.  Minireview: PPARγ as the target of obesogens.

Authors:  Amanda Janesick; Bruce Blumberg
Journal:  J Steroid Biochem Mol Biol       Date:  2011-01-18       Impact factor: 4.292

6.  15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes.

Authors:  Jamie J O'Brien; Sherry L Spinelli; Joanna Tober; Neil Blumberg; Charles W Francis; Mark B Taubman; James Palis; Kathryn E Seweryniak; Jacqueline M Gertz; Richard P Phipps
Journal:  Blood       Date:  2008-08-28       Impact factor: 22.113

7.  The Effect of Baicalin as A PPAR Activator on Erythroid Differentiation of CD133(+)Hematopoietic Stem Cells in Umbilical Cord Blood.

Authors:  Parvaneh Abbasi; Karim Shamsasenjan; Ali Akbar Movassaghpour Akbari; Parvin Akbarzadehlaleh; Nima Dehdilani; Mostafa Ejtehadifar
Journal:  Cell J       Date:  2015-04-08       Impact factor: 2.479

8.  Abdominal Obesity and Insulin Resistance in People Exposed to Moderate-to-High Levels of Dioxin.

Authors:  Jung-Wei Chang; Hsiu-Ling Chen; Huey-Jen Su; Ching-Chang Lee
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

9.  PPARgamma Deficiency Counteracts Thymic Senescence.

Authors:  David Ernszt; Krisztina Banfai; Zoltan Kellermayer; Attila Pap; Janet M Lord; Judit E Pongracz; Krisztian Kvell
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

Review 10.  Linking dioxins to diabetes: epidemiology and biologic plausibility.

Authors:  Rene B J Remillard; Nigel J Bunce
Journal:  Environ Health Perspect       Date:  2002-09       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.